James Giordano, PhD, MPhil
basics is Chief of the Neuroethics Studies Program, and Scholar-in-Residence in the Pellegrino Center for Clinical Bioethics, and is Professor in the Departments of Neurology and Biochemistry at Georgetown University Medical Center, Washington, DC, USA. He is also Distinguished Visiting Professor of Brain Science, Health Promotions and Ethics at the Coburg University of Applied Sciences, Coburg, Germany, and was formerly 2011-2012 JW Fulbright Foundation Visiting Professor of Neurosciences and Neuroethics at the Ludwig-Maximilians University, Munich, Germany.
http://mbyrdphotography.com/amoxil Dr. Giordano currently serves an appointed member of United States Department of Health and Human Services Secretary’s Advisory Council on Human Research Protections (SACHRP); and has served as an appointed member of the Neuroethics, Legal and Social Issues (NELSI) Advisory Panel of the Defense Advanced Research Projects’ Agency (DARPA), and Senior Science Advisory Fellow of the Strategic Multilayer Assessment Branch of the Joint Staff of the Pentagon. He is the author of over 250 publications in neuroscience and neuroethics, 7 books, and 11 government whitepapers on neurotechnology, ethics and biosecurity, he is an Editor-in-Chief of the international journal Philosophy, Ethics and Humanities in Medicine; and Associate Editor of the Cambridge Quarterly of Health Care Ethics.
buy strattera Dr. Giordano’s ongoing research addresses the neurobiological bases of neuropsychiatric spectrum disorders; and neuroethical issues arising in and from the development, use and misuse of neuroscientific techniques and neurotechnologies in medicine, public life, global health, and military applications. In recognition of his work, he was elected to membership in the European Academy of Science and Arts, and was awarded Germany’s Klaus Reichert Prize in Medicine and Philosophy (with longtime collaborator Dr. Roland Benedikter of the University of California at Santa Barbara).
Michael Hoffer, MD, FACS
important source is a Professor of Otolaryngology and Neurological Surgery at the University of Miami. Dr. Hoffer is also the director of the university’s Vestibular and Balance Program. He spent 20-plus years in the Navy studying mild Traumatic Brain Injury (mTBI), tinnitus, hearing loss, and vestibular disorders on active duty service members. As a clinician-scientist, he performs both basic and clinical research along with his Otology/Neurotology practice. Dr. Hoffer focuses much of his research on traumatic damage to the inner ear and brain, including pioneering work on the treatment of noise-induced hearing loss and tinnitus, pharmaceutical countermeasures for mTBI, and optimized diagnosis and management of neurosensory disorders seen after mTBI. He was lead author of the study, “Acute Findings in an Acquired Neurosensory Dysfunction,” published in the peer-reviewed journal Laryngoscope Investigative Otolaryngology. The Miller School study included a review of 25 individuals at the U.S. Embassy in Cuba who reported a localized sensation of noise/pressure and 10 individuals who were roommates of those affected and did not experience the phenomenon.
Dr. Hoffer received his MD from the University of California San Diego School of Medicine, did his residency at the University of Pennsylvania, held a Neurotology Fellowship at the Ear Research Foundation, and received his BS in Biology from Stanford University. He has published extensively and received research grants from the Department of Defense, National Institutes of Health, and industry.
James Canton, PhD
is a renowned global futurist, social scientist, author, and visionary business advisor. As a former Apple Computer executive and high tech entrepreneur, he has been insightfully forecasting the key trends and technologies that have shaped our world. The Economist recognizes him as one of the leading global futurists. He has advised three White House Administrations and over 100 companies. Dr. Canton is CEO and Chairman of the Institute for Global Futures, a leading think tank he founded in 1990 that advises business and government. He was named “the Digital Guru” by CNN and “Dr. Future” by Yahoo for his insights. Dr. Canton is the author of The Extreme Future: The Top Trends That Will Reshape the World in the 21st Century, Dutton 2006, and Technofutures: How Leading-Edge Innovations Will Transform Business in the 21st Century. He advises the Global Fortune 1000 on trends in innovation, financial services, health care, population, life sciences, energy, security, workforce, climate change and globalization. From a broad range of industries, clients include: IBM, Tata, Intel, Philips, General Electric, Hewlett Packard, Boeing, FedEx, and Proctor & Gamble.
Recognized as “one of the top presenters in the 21st century” by Successful Meetings Magazine, Dr. Canton is a highly sought-after keynote presenter. He has spoken to thousands of organizations on five continents. He is noted for his fascinating, informative, dynamic and entertaining keynotes. A frequent guest of the media, Dr. Canton’s media coverage has included CNBC, Fox, PBS, ABC, Fortune, The Wall Street Journal, The Economist, Bloomberg Report, The New York Times, US News and World Report, CEO, CIO and CFO Magazines. His FutureGuru blog and Twitter followers reach a worldwide audience.
Dr. Canton has held a academic appointments at Singularity University at NASA, the Kellogg School of Management, MIT’s Media Lab, Europe, the Potomac Institute, and served on the International Advisory Council, Economic Development Board for the State Singapore, been an advisor to the National Science and Technology Council, US Departments of State, Defense and Health and Human Services.